SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-158545
Filing Date
2022-05-24
Accepted
2022-05-24 16:22:55
Documents
14
Period of Report
2022-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d317841d8k.htm   iXBRL 8-K 47248
2 EX-3.1 d317841dex31.htm EX-3.1 6548
3 EX-3.2 d317841dex32.htm EX-3.2 76854
  Complete submission text file 0001193125-22-158545.txt   286753

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atrs-20220524.xsd EX-101.SCH 2876
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20220524_lab.xml EX-101.LAB 18741
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20220524_pre.xml EX-101.PRE 11721
8 EXTRACTED XBRL INSTANCE DOCUMENT d317841d8k_htm.xml XML 3552
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 22957109
SIC: 3841 Surgical & Medical Instruments & Apparatus